secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001013762-23-003854
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

180 Life Sciences receives Nasdaq non-compliance notice over shareholder approval for offering
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 11, 2023 for violating Listing Rule 5635(d) requiring shareholder approval.
- Offering involved 666,925 shares at $0.65, pre-funded warrants for 3.95M shares at $0.6499, and 4.62M common warrants.
- Nasdaq ruled that the best-efforts offering with one investor buying 98% was not a public offering.
- No immediate impact on listing; Company has 45 days to submit a plan, with possible 180-day extension.
- Company intends to submit a compliance plan but cannot guarantee acceptance or regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000101376223003854/0001013762-23-003854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000101376223003854/ea186707-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-003854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer